← Back to Clinical Trials
Recruiting NCT05432895

NCT05432895 Dynamic Versus Static Night Splinting of Plantar Fasciitis

◆ AI Clinical Summary
Plain-language summary for patients
Clinical Trial Summary
NCT ID NCT05432895
Status Recruiting
Phase
Sponsor Stanford University
Condition Plantar Fascitis
Study Type INTERVENTIONAL
Enrollment 200 participants
Start Date 2023-10-31
Primary Completion 2026-06-18

Trial Parameters

Condition Plantar Fascitis
Sponsor Stanford University
Study Type INTERVENTIONAL
Phase N/A
Enrollment 200
Sex ALL
Min Age 18 Years
Max Age 99 Years
Start Date 2023-10-31
Completion 2026-06-18
Interventions
Dynamic splint

Eligibility Fast-Check

Enter your details for a quick preliminary check. This does not replace medical advice.

Brief Summary

The investigators are trying to study that there is no difference in improvement of motion between static progressive and dynamic splinting.

Eligibility Criteria

Inclusion Criteria: * Demographic - Over 18 years of age and ambulatory without a gait aid with no history of narcotic use * Diagnosis - Unilateral or bilateral acute (\< 6 months of pain) plantar fasciitis (i.e., Heel pain that increases with weightbearing, "First step pain": heel pain that occurs after a period of non-weightbearing, such as in the morning when arising from bed or when arising after prolonged sitting; the pain is improved after a few minutes walking but will worsen again with prolonged weightbearing, tenderness over the medial calcaneal tuberosity at the insertion of the plantar fasciitis) * Permitted - Icing, NSAIDS( ibuprofen), Custom Shoe Inserts, Diagnostic Ultrasound Exclusion Criteria: * Demographic - Under 18 year of age, requires a gait aid for ambulation; if not covered by insurance, * Diagnosis of - Arthritis of the Ankle, Midfoot, or Forefoot; Inflammatory Arthritis; Gout; Turf Toe; Hallux Rigidus; Hallux Limitus; Sesamoiditis; Tendonitis or Tendinopathy; P

Related Trials

ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer  ·  Last Reviewed: April 2026  ·  Data Methodology